Trademarkia Logo

United Kingdom

£
Trademark Search
tCRO

View On IPO.GOV.UK

Registered

on 20 Jan 2023

Last Applicant/ Owned by

ValiRx plc

Stonebridge House, Chelmsford Road, Hatfield Heath

BISHOP'S STORTFORD, Hertfordshire, CM22 7BD

Serial Number

UK00003869887 filed on 20th Jan 2023

Registration Number

UK00003869887 registered on
21st Apr 2023

tCRO

drug delivery agents;pharmaceutical drugs;drug delivery agents that facilitate the delivery of pharmaceutical preparations;drug delivery agents in the Read More

Classification Information

Class [5]
Pharmaceutical Products

Drug delivery agents;Pharmaceutical drugs;Drug delivery agents that facilitate the delivery of pharmaceutical preparations;Drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations;Anti-cancer drugs;Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations;Drug detoxifying agents;Antitumor drugs;Antineoplastic drugs;Pharmaceutical preparations and substances for the treatment of cancer;Antituberculous drugs;Antimigraine drugs;Pharmaceutical preparations and substances for the prevention of cancer;Antiseizure drugs;Pharmaceutical preparations and substances for use in oncology;Pharmaceutical preparations for the treatment of cancer;Hypoglycemic drugs;Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals;Antiepileptic drugs;Pharmaceutical products for the treatment of depression;Antiviral drugs for treating HIV;Pharmaceutical preparations for the treatment of Parkinson's disease;Pharmaceutical preparations for the treatment of epilepsy;Cytostatic drugs for medical purposes;Pharmaceutical products for the treatment of cancer;Pharmaceutical preparations for the treatment of osteoporosis;Dermatological pharmaceutical substances;Pharmaceutical preparations for the treatment of viral diseases;Antiviral drugs for treating influenza;Hormone preparations for pharmaceutical use;Injectable pharmaceuticals for treatment of anaphylactic reactions;Crude drugs;Pharmaceutical preparations for the treatment of cardiovascular disease;Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;Pharmaceutical preparations for the treatment of multiple sclerosis;Oral anti-epileptic pharmaceutical preparations;Pharmaceutical products for the treatment of viral diseases;Pharmaceutical agents affecting metabolism;Anti-epileptic pharmaceutical preparations;Pharmaceutical preparations for use in oncology;Alcohol for pharmaceutical purposes;Pharmaceutical preparations for the prevention of osteoporosis;Pharmaceutical preparations for the treatment of bone diseases;Organotherapeutic drugs;Pharmaceutical preparations for the prevention of diabetes;Pharmaceutical preparations for the treatment of infectious diseases;Pharmaceutical preparations for the treatment of diseases of the metabolic system;Diagnostic agents for pharmaceutical use;Pharmaceutical for the treatment of erectile dysfunction;Pharmaceutical preparations and substances;Pharmaceutical preparations for the treatment of autoimmune diseases;Pharmaceutical preparations and substances with analgesic properties;Pharmaceutical preparations for the treatment of gout;Drugs for medical purposes;Pharmaceutical preparations for the treatment of autoimmune disorders;Pharmaceutical preparations and substances for use in the field of anesthesia;Pharmaceutical preparations containing caffeine;Antibacterials for pharmaceutical use;Pharmaceutical preparations for the treatment of kidney diseases;Pharmaceutical preparations for inducing erections;Narcotics;Cocaine for medical purposes;Pharmaceutical preparations for the treatment of disorders of the metabolic system;Pharmaceutical preparations for use in chemotherapy;Pharmaceutical preparations for the treatment of hypercholesteremia;Autonomic drugs;Pharmaceutical preparations for human use;Pharmaceutical preparations for the treatment of tumours;Pharmaceutical products for the treatment of bone diseases;Pharmaceutical products for the treatment of infectious diseases;Pharmaceutical preparations for suppressing tumors;Pharmaceutical preparations for use in discouraging the smoking habit;Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension;Pharmaceutical preparations for the prevention of diseases of the metabolic system;Pharmaceutical preparations for the treatment of heart rhythm disorders;Pharmaceutical preparations for the prevention of tumours;Pharmaceutical preparations and substances for use in urology;Pharmaceutical preparations for the treatment of kidney disorders;Parenteral anti-epileptic pharmaceutical preparations;Pharmaceutical preparations for the treatment of hormonal disorders;Anti-cancer preparations of chemical origin;Pharmaceutical preparations for the treatment of esophagitis;Pharmaceutical antiallergic preparations and substances;Pharmaceutical preparations for the treatment of disorders caused by bacteria;Effervescent analgesic pharmaceutical preparations;Pharmaceutical preparations for the treatment of bone fractures;Pharmaceutical preparations for the prevention of disorders of the metabolic system;Pharmaceutical preparations for the prevention of autoimmune disorders;Chemical preparations for use in dna analysis [medical];Cardiovascular drugs used in treating shocks;Pharmaceutical preparations for the prevention of autoimmune diseases;Pharmaceutical preparations for the treatment of diseases caused by bacteria;Pharmaceutical preparations for the treatment of diseases of the endocrine system;Pharmaceutical preparations for the treatment of hyperlipidemia;Pharmaceutical preparations and substances with anti-inflammatory properties;Pharmaceutical preparations and substances for use in gynecology;Pharmaceutical preparations for the prevention of ocular diseases;Anti-diabetic pharmaceuticals;Synthetic narcotics;Pharmaceutical preparations for the prevention of ocular disorders.

Class [42]
Computer & Software Services & Scientific Services

Drug discovery services;Pharmaceutical drug development services;Pharmaceutical research and development;Development of pharmaceutical preparations and medicines;Conducting clinical trials for pharmaceutical products;Research and development of vaccines and medicines;Testing of pharmaceuticals;Research and development for the pharmaceutical industry;Research of pharmaceuticals;Pharmaceutical research and development services;Providing medical and scientific research information in the field of pharmaceuticals and clinical trials;Research relating to pharmaceuticals;Pharmaceutical products development;Research and development in the pharmaceutical and biotechnology fields;Pharmaceutical product evaluation;Development of software for Automated Business Process Discovery (ABPD);Scientific and technological research relating to patent mapping;Providing information about the results of clinical trials for pharmaceutical products;Pharmaceutical research services;Laboratory research services relating to pharmaceuticals;Chemical research;Biochemical research and development.

Mark Details

Serial Number

UK00003869887

Mark Type

Word

Kind of mark

Individual